4.7 Article

High Plasma Interleukin-18 Levels Mark the Acute Phase of Hepatitis C Virus Infection

Journal

JOURNAL OF INFECTIOUS DISEASES
Volume 204, Issue 11, Pages 1730-1740

Publisher

OXFORD UNIV PRESS INC
DOI: 10.1093/infdis/jir642

Keywords

-

Funding

  1. National Institutes of Health [U19 AI09025, R0113324, R01AI077757]

Ask authors/readers for more resources

Background. Proinflammatory cytokines play a critical role in antiviral immune responses. Large-scale genome studies have found correlations between single-nucleotide polymorphisms (SNPs) in the interleukin (IL) 18 promoter and spontaneous control of hepatitis C virus (HCV), suggesting a role in clearance. Methods. Plasma IL-18, IL-1 beta, IL-6, IL-8, IL-12, interferon-gamma, tumor necrosis factor-alpha, alanine aminotransferase (ALT), and HCV RNA levels were assessed longitudinally in subjects with known dates of HCV acquisition and analyzed according to IL-18 SNPs and outcome, either spontaneous clearance (SC) (n = 13) or persistent infection (PI) (n = 25). Results. No significant change in plasma proinflammatory cytokine expression was observed with the exception of IL-18, which increased in every subject with initial detection of HCV RNA. In every SC subject, IL-18 returned to the preinfection baseline concomitant with HCV control. In PI subjects, IL-18 declined following the acute phase of infection but remained above the preinfection baseline throughout chronic infection and did not correlate with HCV RNA or ALT levels. Conclusions. Plasma IL-18 was an early and the most reliably detected host response to HCV infection measured in blood. Reduced IL-18 production with transition to chronic infection without correlation with HCV RNA or ALT levels suggests modulation of the innate response with persistent infection.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Editorial Material Public, Environmental & Occupational Health

Opioids, Hepatitis C Virus Infection, and the Missing Vaccine

Kimberly Page, Andrea Cox, Paula J. Lum

AMERICAN JOURNAL OF PUBLIC HEALTH (2018)

Article Infectious Diseases

Complex patterns of Hepatitis-C virus longitudinal clustering in a high-risk population

Rebecca Rose, Susanna L. Lamers, Guido Massaccesi, William Osburn, Stuart C. Ray, David L. Thomas, Andrea L. Cox, Oliver Laeyendecker

INFECTION GENETICS AND EVOLUTION (2018)

Article Gastroenterology & Hepatology

Approaches, Progress, and Challenges to Hepatitis C Vaccine Development

Justin R. Bailey, Eleanor Barnes, Andrea L. Cox

GASTROENTEROLOGY (2019)

Article Gastroenterology & Hepatology

Multi-Ancestry Genome-Wide Association Study of Spontaneous Clearance of Hepatitis C Virus

Candelaria Vergara, Chloe L. Thio, Eric Johnson, Alex H. Kral, Thomas R. O'Brien, James J. Goedert, Alessandra Mangia, Valeria Piazzolla, Shruti H. Mehta, Gregory D. Kirk, Arthur Y. Kim, Georg M. Lauer, Raymond T. Chung, Andrea L. Cox, Marion G. Peters, Salim I. Khakoo, Laurent Alric, Matthew E. Cramp, Sharyne M. Donfield, Brian R. Edlin, Michael P. Busch, Graeme Alexander, Hugo R. Rosen, Edward L. Murphy, Rachel Latanich, Genevieve L. Wojcik, Margaret A. Taub, Ana Valencia, David L. Thomas, Priya Duggal

GASTROENTEROLOGY (2019)

Article Gastroenterology & Hepatology

Genomic variability of within-host hepatitis C variants in acute infection

Chaturaka Rodrigo, Preston Leung, Andrew R. Lloyd, Rowena A. Bull, Fabio Luciani, Jason Grebely, Gregory J. Dore, Tanya Applegate, Kimberly Page, Julie Bruneau, Andrea L. Cox, William Osburn, Arthur Y. Kim, Naglaa H. Shoukry, Georg M. Lauer, Lisa Maher, Janke Schinkel, Maria Prins, Margaret Hellard, Auda A. Eltahla

JOURNAL OF VIRAL HEPATITIS (2019)

Article Virology

Broadly Neutralizing Antibodies Targeting New Sites of Vulnerability in Hepatitis C Virus E1E2

Michelle D. Colbert, Andrew Flyak, Clinton O. Ogega, Valerie J. Kinchen, Guido Massaccesi, Mayda Hernandez, Edgar Davidson, Benjamin J. Doranz, Andrea L. Cox, James E. Crowe, Justin R. Bailey

JOURNAL OF VIROLOGY (2019)

Article Medicine, General & Internal

Trends in hepatitis C treatment initiation among HIV/hepatitis C virus-coinfected men engaged in primary care in a multisite community health centre in Maryland: a retrospective cohort study

Yun-Chi Chen, Chloe L. Thio, Andrea L. Cox, Sebastian Ruhs, Farin Kamangar, Kjell J. Wiberg

BMJ OPEN (2019)

Article Infectious Diseases

Inconsistent temporal patterns of genetic variation of HCV among high-risk subjects may impact inference of transmission networks

Rebecca Rose, Christopher Rodriguez, James Jarad Dollar, Susanna L. Lamers, Guido Massaccesi, William Osburn, Stuart C. Ray, David L. Thomas, Andrea L. Cox, Oliver Laeyendecker

INFECTION GENETICS AND EVOLUTION (2019)

Article Infectious Diseases

Genomic characterization of hepatitis C virus transmitted founder variants with deep sequencing

Arunasingam Abayasingam, Preston Leung, Auda Eltahla, Rowena A. Bull, Fabio Luciani, Jason Grebely, Gregory J. Dore, Tanya Applegate, Kimberly Page, Julie Bruneau, Andrea L. Cox, Arthur Y. Kim, Janke Schinkel, Naglaa H. Shoukry, Georg M. Lauer, Lisa Maher, Margaret Hellard, Maria Prins, Andrew Lloyd, Chaturaka Rodrigo

INFECTION GENETICS AND EVOLUTION (2019)

Article Medicine, Research & Experimental

Plasma deconvolution identifies broadly neutralizing antibodies associated with hepatitis C virus clearance

Valerie J. Kinchen, Guido Massaccesi, Andrew Flyak, Madeleine C. Mankowski, Michelle D. Colbert, William O. Osburn, Stuart C. Ray, Andrea L. Cox, James E. Crowe, Justin R. Bailey

JOURNAL OF CLINICAL INVESTIGATION (2019)

Article Multidisciplinary Sciences

Herpes simplex virus type 1 inflammasome activation in proinflammatory human macrophages is dependent on NLRP3, ASC, and caspase-1

Andrew H. Karaba, Alexis Figueroa, Guido Massaccesi, Sara Botto, Victor R. DeFilippis, Andrea L. Cox

PLOS ONE (2020)

Article Immunology

Interleukin-18 and tumor necrosis factor-α are elevated in solid organ transplant recipients with possible cytomegalovirus end-organ disease

Andrew H. Karaba, Alexis Figueroa, William A. Werbel, Maria Veronica Dioverti, Seema Mehta Steinke, Stuart C. Ray, Andrea L. Cox, Robin K. Avery

Summary: IL-18 and TNF-alpha could serve as potential non-invasive markers to distinguish solid organ transplant recipients with possible end-organ CMV disease.

TRANSPLANT INFECTIOUS DISEASE (2021)

Article Microbiology

B cell overexpression of FCRL5 and PD-1 is associated with low antibody titers in HCV infection

Clinton O. Ogega, Nicole E. Skinner, Andrew I. Flyak, Kaitlyn E. Clark, Nathan L. Board, Pamela J. Bjorkman, James E. Crowe Jr, Andrea L. Cox, Stuart C. Ray, Justin R. Bailey

Summary: Antibodies targeting the HCV envelope glycoprotein E2 are associated with delayed disease progression and spontaneous clearance of infection. However, many infected individuals show suboptimal anti-E2 antibody responses. This study investigated the mechanisms underlying these responses and found that upregulation of FCRL5 on memory B cells and PD-1 on activated B cells may limit anti-E2 antibody production. Strategies to limit the upregulation of these molecules could potentially generate higher titers of protective antibodies against HCV or other pathogens.

PLOS PATHOGENS (2022)

Article Multidisciplinary Sciences

The D614G mutation redirects SARS-CoV-2 spike to lysosomes and suppresses deleterious traits of the furin cleavage site insertion mutation

Chenxu Guo, Shang-Jul Tsai, Yiwei Ai, Maggie Li, Eduardo Anaya, Andrew Pekosz, Andrea Cox, Stephen J. Gould

Summary: The D614G mutation in SARS-CoV-2 enhances Spike protein trafficking to lysosomes, reprograms lysosomes, and reduces cell surface Spike expression. This mutation is not specific to humans, but rather an adaptation to an earlier furin cleavage site insertion mutation. The D614G mutation restores Spike trafficking to lysosomes and enhances the earliest events in SARS-CoV-2 infectivity.

SCIENCE ADVANCES (2022)

Article Immunology

The Effect of Female Sex on Hepatitis C Incidence Among People Who Inject Drugs: Results From the International Multicohort InC3 Collaborative

Aryan Esmaeili, Ali Mirzazadeh, Meghan D. Morris, Behzad Hajarizadeh, Henry S. Sacks, Lisa Maher, Jason Grebely, Arthur Y. Kim, Georg Lauer, Andrea L. Cox, Margaret Hellard, Paul Dietze, Julie Bruneau, Naglaa H. Shoukry, Gregory J. Dore, Andrew R. Lloyd, Maria Prins, Kimberly Page

CLINICAL INFECTIOUS DISEASES (2018)

No Data Available